Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-953-3 | CAS number: 28305-25-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
According to the REACH guidance on information requirements and chemical safety assessment a leading DN(M) EL needs to be derived for every relevant human population and every relevant route, duration and frequency of exposure, if feasible.
Calcium lactate is a food ingredient, and it is used as a food additive both in Europe and in the US. It is classified as a GRAS (Generally Recognised As Safe) substance by FAO, with an unlimited ADI (Acceptable Daily Intake). In the EU, calcium lactate as a food additive is given thequantum satisstatus, which means that no maximum numerical level is specified (EU Regulation No 1129/2011) based on the evaluation by JECFA [1].
Only one limited study is available, adressing repeated exposure to calcium lactate (Matsushimaet al., 1989; only publication available). In this study, exposure of rats to 5% calcium lactate in drinking water resulted in minor toxicological findings, which could not be supported by histopathological data. The NOAEL was set at 1840 mg/kg bw, which was the highest dose tested.
Since calcium lactate fully dissociates into Ca2+ions and lactate- in aqueous solutions and/or physiological conditions, its toxicological profile (systemic endpoints) was described to a great extent based on information on the toxicity of lactic acid, calcium and calcium chloride (see read across statement attached in section 13).
Lactic acid is a common biological molecule, with low acute and no chronic toxicity, to which humans are continuously exposed, from diet (as a natural food ingredient), from bacterial generation in the gut, and from intra-mitochondrial (innate) processes. Natural concentrations in vivo can and will vary widely. Lactic acid is also applied in foodstuffs as food additive, with a no established ADI (EURegulation No 1129/2011). A more elaborate explanation on the biology and human exposure to lactic acid can be found in the document attached in the Section 7.1.1 (Sterenborg, 2007) of this IUCLID5 file.The information presented in this document unambiguously shows that exposure to lactic acid is a normal aspect of human life. Therefore, it is considered unnecessary to derive a DNEL for lactic acid.
Similarly, calcium is an essential nutrient for humans, with a strict self regulatory system. As a natural constituent of man, animals and plants it occurs in several foodstuffs. The European Committe categorizes calcium cation in a group of substances were no ADI is specified, despite the fact that exhaustive systematic toxicological data with the individual cation are not available [2]. According to EFSA, the tolerable upper intake level for calcium is set at 2500 mg per day for healthy humans [3], based on various interventional studies of long duration in adults, in which total daily calcium intakes of 2500 mg from both diet and oral supplements were tolerated without adverse effects.This level is also supported by the IOM in the US [4]: “Currently, the available data on the adverse effects of excess calcium intake in humans primarily concerns calcium intake from nutrient supplements. Of the many possible adverse effects of excessive calcium intake, the three most widely studied and biologically important are: kidney stone formation (nephrolithiasis), the syndrome of hypercalcemia and renal insufficiency with and without alkalosis (referred to historically as milk-alkali syndrome when associated with a constellation of peptic ulcer treatments), and the interaction of calcium with the absorption of other essential minerals. These are not the only adverse effects associated with excess calcium intake. However, the vast majority of reported effects are related to or result from one of these three conditions”[4]. The reviews of EFSA[3] and IOM[4&5] are summarized under section 7.12.
Considering the above information, derivation of a DNEL on systemic effects for calcium lactate is considered irrelevant.
Endpoints related to local effects were adressed with the substance itself. Calcium lactate is not a skin or eye irritant and therefore, no DNEL needs to be derived for local effects.
[1]Joint FAO/WHO Expert Committee on Food Additives, 1973; Tox MonographFAS 5/NMRS 53A-JECFA 17/461
[2] Report of the Scientific Committee for Food, 1990; 13416 EN
[3] EFSA. Scientific Opinon on the Tolerable Upper Intake Level of Calcium, 2012; EFSA Journal 2012;10(7):2814
[4]Institute of Medicine. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997
[5]Institute of Medicine. DRI Dietary Reference Intakes Calcium Vitamin D, 2011.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
According to the REACH guidance on information requirements and chemical safety assessment a leading DN(M) EL needs to be derived for every relevant human population and every relevant route, duration and frequency of exposure, if feasible.
Calcium lactate is a food ingredient, and it is used as a food additive both in Europe and in the US. It is classified as a GRAS (Generally Recognised As Safe) substance by FAO, with an unlimited ADI (Acceptable Daily Intake). In the EU, calcium lactate as a food additive is given thequantum satisstatus, which means that no maximum numerical level is specified (EURegulation No 1129/2011) based on the evaluation by JECFA [1].
Only one limited study is available, adressing repeated exposure to calcium lactate (Matsushimaet al., 1989; only publication available). In this study, exposure of rats to 5% calcium lactate in drinking water resulted in minor toxicological findings, which could not be supported by histopathological data. The NOAEL was set at 1840 mg/kg bw, which was the highest dose tested.
Since calcium lactate fully dissociates into Ca2+ions and lactate- in aqueous solutions and/or physiological conditions, its toxicological profile (systemic endpoints) was described to a great extent based on information on the toxicity of lactic acid, calcium and calcium chloride (see read across statement attached in section 13).
Lactic acid is a common biological molecule, with low acute and no chronic toxicity, to which humans are continuously exposed, from diet (as a natural food ingredient), from bacterial generation in the gut, and from intra-mitochondrial (innate) processes. Natural concentrations in vivo can and will vary widely. Lactic acid is also applied in foodstuffs as food additive, with a no established ADI (EURegulation No 1129/2011). A more elaborate explanation on the biology and human exposure to lactic acid can be found in the document attached in the Section 7.1.1 (Sterenborg, 2007) of this IUCLID5 file.The information presented in this document unambiguously shows that exposure to lactic acid is a normal aspect of human life. Therefore, it is considered unnecessary to derive a DNEL for lactic acid.
Similarly, calcium is an essential nutrient for humans, with a strict self regulatory system. As a natural constituent of man, animals and plants it occurs in several foodstuffs. The European Committe categorizes calcium cation in a group of substances were no ADI is specified, despite the fact that exhaustive systematic toxicological data with the individual cation are not available [2]. According to EFSA, the tolerable upper intake level for calcium is set at 2500 mg per day for healthy humans [3], based on various interventional studies of long duration in adults, in which total daily calcium intakes of 2500 mg from both diet and oral supplements were tolerated without adverse effects.This level is also supported by the IOM in the US [4]: “Currently, the available data on the adverse effects of excess calcium intake in humans primarily concerns calcium intake from nutrient supplements. Of the many possible adverse effects of excessive calcium intake, the three most widely studied and biologically important are: kidney stone formation (nephrolithiasis), the syndrome of hypercalcemia and renal insufficiency with and without alkalosis (referred to historically as milk-alkali syndrome when associated with a constellation of peptic ulcer treatments), and the interaction of calcium with the absorption of other essential minerals. These are not the only adverse effects associated with excess calcium intake. However, the vast majority of reported effects are related to or result from one of these three conditions”[4]. The reviews of EFSA[3] and IOM[4&5] are summarized under section 7.12.
Considering the above information, derivation of a DNEL on systemic effects for calcium lactate is considered irrelevant.
Endpoints related to local effects were adressed with the substance itself. Calcium lactate is not a skin or eye irritant and therefore, no DNEL needs to be derived for local effects.
[1]Joint FAO/WHO Expert Committee on Food Additives, 1973; Tox MonographFAS 5/NMRS 53A-JECFA 17/461
[2] Report of the Scientific Committee for Food, 1990; 13416 EN
[3] EFSA.Scientific Opinon on the Tolerable Upper Intake Level of Calcium, 2012; EFSA Journal 2012;10(7):2814
[4]Institute of Medicine. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997
[5]Institute of Medicine. DRI Dietary Reference Intakes Calcium Vitamin D, 2011.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.